Position in EW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$75,525,054
-$23,021,394 QoQ
Shares Held
834,900
-32.2% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
#84
of 1,315 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Derivatives in EW
reported options exposure · as of Dec 31, 2025CallValue
$12,787,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $218,961,143 across 6 Medical Devices names. EW ranks #1 (34.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
This page
|
834,900 | $75,525,054 | |
| 2 | BSX |
Boston Scientific Corp
|
1,483,200 | $63,302,976 | |
| 3 | SYK |
Stryker Corp
|
159,100 | $50,091,044 | |
| 4 | NPCE |
NeuroPace Inc
|
1,505,125 | $23,916,436 | |
| 5 | AORT |
Artivion, Inc.
|
175,000 | $3,932,250 | |
| 6 | NSPR |
InspireMD, Inc.
|
3,133,405 | $2,193,383 |
All Filings in EW
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,525,054 | 834,900 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $98,546,448 | 1,230,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $157,107,225 | 1,842,900 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $12,787,500 | 150,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $130,964,680 | 1,684,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $133,582,680 | 1,708,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $111,039,360 | 1,532,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $84,786,707 | 1,145,302 | Shares | Sole | 2025-02-14 | |
| 2023-06-30 | $48,579,950 | 515,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $52,119,900 | 630,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $64,201,905 | 860,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $79,845,369 | 966,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $96,164,517 | 1,011,300 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $123,759,036 | 1,051,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $139,421,710 | 1,076,200 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $127,519,744 | 1,126,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $116,661,248 | 1,126,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $94,212,096 | 1,126,400 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $93,583,734 | 1,025,800 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $56,392,830 | 706,500 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $36,655,944 | 530,400 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $33,347,998 | 176,800 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||